Strs Ohio Invests $1.54 Million in The Clorox Company $CLX

Strs Ohio purchased a new position in The Clorox Company (NYSE:CLX - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,437 shares of the company's stock, valued at approximately $1,537,000.

A number of other hedge funds have also made changes to their positions in CLX. Wood Tarver Financial Group LLC purchased a new stake in shares of Clorox in the fourth quarter worth approximately $31,000. Ransom Advisory Ltd purchased a new stake in shares of Clorox in the first quarter worth approximately $35,000. GW&K Investment Management LLC lifted its position in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after purchasing an additional 208 shares in the last quarter. Roble Belko & Company Inc lifted its position in shares of Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock worth $53,000 after purchasing an additional 211 shares in the last quarter. Finally, IMA Advisory Services Inc. acquired a new position in Clorox in the first quarter worth approximately $58,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on CLX. JPMorgan Chase & Co. increased their price objective on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a report on Monday, September 8th. Citigroup restated a "neutral" rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Jefferies Financial Group dropped their price objective on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Morgan Stanley dropped their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Finally, Wells Fargo & Company dropped their price objective on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a report on Friday, September 5th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Clorox currently has an average rating of "Reduce" and a consensus target price of $142.18.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company's stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is currently owned by company insiders.

Clorox Stock Up 1.6%

CLX opened at $124.79 on Wednesday. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market capitalization of $15.26 billion, a price-to-earnings ratio of 19.14, a P/E/G ratio of 0.99 and a beta of 0.52. The business has a 50 day moving average of $124.22 and a 200-day moving average of $131.86.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. During the same period in the prior year, the business earned $1.82 earnings per share. Clorox's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.0%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox's dividend payout ratio (DPR) is 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.